Acute myeloid leukaemia in the elderly: a review-Reference-Cited by-同舟云学术

Acute myeloid leukaemia in the elderly: a review

Published:2011-02-14 Issue:5 Volume:152 Page:524-542
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Pollyea Daniel A.,Kohrt Holbrook E.,Medeiros Bruno C.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2010.08470.x/fullpdf

Reference195 articles.

1. FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group;Abu-Duhier;British Journal of Haematology,2000

2. Levels of soluble HLA-I and beta2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy;Albitar;Leukemia,2007

3. Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age;Alyea;Blood,2005

4. Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups;Amadori;Haematologica,2004

5. Gemtuzumab ozogamicin (Mylotarg) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell’Adulto Leukemia Groups;Amadori;Leukemia,2005

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metronomic chemotherapy in hematology: Lessons from preclinical and clinical studies to build a solid rationale for future schedules;Cancer Letters;2024-06

2. Pracinostat combined with azacitidine in newly diagnosed adult acute myeloid leukemia (AML) patients unfit for standard induction chemotherapy: PRIMULA phase III study;Leukemia Research;2024-05

3. Bone marrow microRNA-34a is a good indicator for response to treatment in acute myeloid leukemia;Oncology Research;2024

4. Prognostic significance of ASXL1 mutations in acute myeloid leukemia: A systematic review and meta-analysis;CASP J INTERN MED;2024

5. How to adjust therapy for elderly AML patients in developing countries?;The Egyptian Journal of Haematology;2023-10